Trials / Terminated
TerminatedNCT00244894
Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer
Acupuncture for Hot Flashes in Prostate Cancer Patients
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- OHSU Knight Cancer Institute · Academic / Other
- Sex
- Male
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Acupuncture may help relieve hot flashes in patients with prostate cancer. PURPOSE: This clinical trial is studying how well acupuncture works in treating hot flashes in patients with prostate cancer who are undergoing androgen deprivation.
Detailed description
OBJECTIVES: * Determine the impact of acupuncture therapy on the frequency and intensity of hot flashes and the quality of life of patients with prostate cancer undergoing androgen deprivation. * Determine if blood serotonin and urinary 5-HIAA are increased in patients treated with acupuncture. * Determine if plasma calcitonin gene-related peptide and MHPG are reduced in patients with hot flashes due to androgen deprivation treated with acupuncture. * Determine the ability of tongue diagnosis, a traditional Chinese clinical assessment method, to predict clinical and biological changes in these patients. * Determine the effect of acupuncture on insomnia and loss of vitality caused by hot flashes in these patients. OUTLINE: Patients undergo acupuncture for 30 minutes twice weekly for 4 weeks and then once weekly for an additional 6 weeks. Quality of life is assessed at baseline, at weeks 2, 4, 6, and 10, and then at 6 weeks after completion of study treatment. After completion of study treatment, patients are followed at 6 weeks. PROJECTED ACCRUAL: A total of 25 patients will be accrued for this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | acupuncture therapy | Acupuncture treatments will be administered by a qualified practitioner twice a week for the first four weeks and once per week for an additional 6 weeks. Sterile, disposable Seirin needles will be placed bilaterally at the point Gallbladder 34, and along the spine at Bladder 15, Bladder 23, and Bladder 32. Low intensity electrostimulation at 2 Hz will be used for both Bladder 23 and Bladder 32. Points will also be placed unilaterally at Governing vessel 20, Heart 7, Pericardium 6, Liver 2, and Spleen 6 |
| PROCEDURE | fatigue assessment and management | Patients will utilize the Pittsburgh Sleep Quality Index (PSQI) to assess if the patient is an overall good sleeper or a poor sleeper. |
| PROCEDURE | hot flashes attenuation | Patients will be asked to report hot flash frequency and severity daily using the hot flash diary (HFD) and hot flash severity guidelines (HFSG) throughout the treatment period. |
| PROCEDURE | management of therapy complications | Short Form Health Survey (SF-36) will be used to assess the patient's overall vitality. |
| PROCEDURE | quality-of-life assessment | Hot Flash Related Daily Interference Scale (HFRDIS)will be used to self-report hot flash related quality of life. |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2005-10-27
- Last updated
- 2017-04-28
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00244894. Inclusion in this directory is not an endorsement.